Obsessive -compulsive disorder. Obsessive-compulsive disorder
Conditions
Interventions
Intervention 1: Sertraline tablets at a dose of 100-300 mg per day (depending on patient tolerance) with 7.5 to 30 mg of mirtazapine daily for 12 weeks as an intervention group. Intervention 2: Sertra
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: people who have been diagnosed with obsessive -compulsive disorder based on DSM5. People with a yale-brown obsessive compulsive scale above 15. Has an age range of 18 to 60 years.
Exclusion criteria
Exclusion criteria: Pregnant women and breastfeeding People receivinig psychotherapy. having major physical illnesse: liver problems (they have high liver enzymes),kidney problems(BUN ,CR are high), thyroid problem, trouble breathing. They have other psychiatric problems: According to the DSM5 criteria, they have psychotic disorder, anxiety disorder, dementia, mood disorder, and mental retardation. use drugs or alcohol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The severity of the symptoms of obsessive -compulsive disorder. Timepoint: The beginning of the study and 2-4-6-8-12 weeks after the start of treatment. Method of measurement: Based on the questionnaire Y-BOCS. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHaniyeh baniasadipour
Shiraz University of Medical Sciences
Outcome results
None listed